NEJM Evidence

Published by: Massachusetts Medical Society  

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. Cuello
    Cuello
  3. Devlin
    Devlin
  4. Park
    Park
  5. Tallman
    Tallman
  6. Vemuri
    Vemuri

Groups

  1. Adult Leukemia (1)
  2. Advanced Practice Providers (1)
  3. Biostatistics Service (1)
  4. Center for Hematologic Malignancies (1)
  5. Department of Medicine (1)
  6. Epidemiology and Biostatistics (1)
  7. Executive Committee, Center for Hematologic Malignancies (1)
  8. GSK Faculty (1)
  9. Hematologic Malignancies, Division of (1)
  10. Nursing (1)
Search Within
  1. "Biostatistics Service"
Formats
  1. Journal Article (1)
Groups
  1. Adult Leukemia (1)
  2. Advanced Practice Providers (1)
  3. Biostatistics Service (1)
  4. Center for Hematologic Malignancies (1)
  5. Department of Medicine (1)
  6. Epidemiology and Biostatistics (1)

More Groups

People
  1. Benjamin Durham (1)
  2. Bernadette Cuello (1)
  3. Jae Park (1)
  4. Madhulika Shukla (1)
  5. Martin Tallman (1)
  6. Omar Abdel-Wahab (1)

More People

Years
  1. 2023 (1)
Publishers
  1. Massachusetts Medical Society (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia
    Journal Article

    Park, J. H.; Devlin, S.; Durham, B. H.; Winer, E. S.; Huntington, S.; von Keudell, G.; Vemuri, S.; Shukla, M.; Falco, V.; Cuello, B.; more...
    NEJM Evidence (2023)

    Fulltext@MSK | Save

    • NEJM Evidence – authorized name for:

    Name ISSN / ISBN Publisher
    NEJM Evidence 2766-5526 Massachusetts Medical Society
    NEJM Evidence 2766-5526 Massachusetts Medical Society